EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study

Shujun Kong, Jianan Sun, Xiaolong Sui, Shuaizhi Zhang, YuanBao Qi, Yuanxu Ma, Sijian Li iD

Acta Obstetricia et Gynecologica Scandinavica · 2023

DOI: 10.1111/aogs.14578 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2023. Verfasst von Shujun Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China. Hauptthemen laut MEDLINE: Struma Ovarii, Carcinoid Tumor, Ovarian Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Primary ovarian carcinoids are extremely rare ovarian tumors, and there is limited data available on their clinical characteristics and survival outcomes. Material and methods We conducted a historical cohort study of 56 patients to investigate their clinical characteristics. The overall survival, disease‐specific survival, recurrence‐free survival, and potential prognostic factors of these patients were also evaluated.

Results

The median age of these patients was 42.0 years (range: 20–71). The average mass and carcinoid size was 7.3 and 0.4 cm, respectively. Elevated tumor marker levels and ascites were observed in 15 and 10 patients, respectively. In 98.2% of the patients, tumors were confined to the ovary, while only one had metastatic disease. Surgery was the mainstay therapy: 37.5% of the patients underwent unilateral salpingo‐oophorectomy, 25.0% underwent hysterectomy with bilateral salpingo‐oophorectomy, 21.4% underwent ovarian cystectomy, 10.7% underwent comprehensive staging surgery, and 5.4% underwent bilateral salpingo‐oophorectomy. Appendectomy and lymphadenectomy were performed in eight and five patients, respectively, but none showed tumor involvement. Chemotherapy was the only adjuvant treatment utilized, and was administered in four patients. Pathological analysis showed that strumal carcinoid was the most predominant subtype, occurring in 66.1% of the patients. The Ki‐67 index was reported in 39 patients, 30 of which had an index of no more than 3%, with a maximum of only 5%. Only one relapse occurred after the initial treatment, and that patient experienced recurrences on two occasions, maintaining stable disease after surgery and octreotide therapy. After a median follow‐up of 3.6 years, 96.4% of the patients achieved no evidence of disease, while 3.6% were alive with the disease. The 5‐year recurrence‐free survival rate was 97.9% and no death occurred. No risk factors for recurrence‐free survival, overall survival, or disease‐specific survival were identified.

Conclusions

The Ki‐67 indices were extremely low and prognoses were excellent in patients with primary ovarian carcinoids. Conservative surgery, especially unilateral salpingo‐oophorectomy, is preferred. Individualized adjuvant therapy may be considered for patients with metastatic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Struma OvariiCarcinoid TumorOvarian NeoplasmsAdultYoung AdultRetrospective StudiesCohort StudiesStomach NeoplasmsPancreatic NeoplasmsAgedNeoplasm Recurrence, LocalMiddle AgedIntestinal NeoplasmsNeoplasm StagingNeuroendocrine TumorsFemaleHumansKi-67 Antigen

Stichwörter der Autor:innen

adjuvant therapy; survival outcomesclinical characteristicsovarian carcinoidsurgery

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Department of Pathology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Department of Medical Record and Information, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

ORCID-Profile: Sijian Li

Zitieren

APA

Kong, S., Sun, J., Sui, X., Zhang, S., Qi, Y., Ma, Y., & Li, S. (2023). Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14578

Vancouver

Kong S, Sun J, Sui X, Zhang S, Qi Y, Ma Y, et al. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14578

BibTeX
@article{Kong2023,
  author = {Kong, Shujun and Sun, Jianan and Sui, Xiaolong and Zhang, Shuaizhi and Qi, YuanBao and Ma, Yuanxu and Li, Sijian},
  title = {Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2023},
  doi = {10.1111/aogs.14578}
}
Kostenlos starten →